Đang chuẩn bị liên kết để tải về tài liệu:
Alternative dosing of dual PI3K and MEK inhibition in cancer therapy

PI3K/AKT/mTOR and RAS/RAF/MEK/ERK pathways are thought to be the central transducers of oncogenic signals in solid malignancies, and there has been a lot of enthusiasm for developing inhibitors of these pathways for cancer therapy. |